Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 1,549 | 6,431 | 1,385 | 1,250 | 570 |
| Gross Profit | 1,549 | 6,431 | 1,385 | 1,250 | 570 |
| Operating Expenses | 31,099 | 16,282 | 22,021 | 16,527 | 15,918 |
| Operating Income | -29,550 | -9,851 | -20,636 | -15,277 | -15,348 |
| Interest Expense | 1,938 | 1,362 | 1,274 | 1,351 | 1,309 |
| Other Income | 0 | 3,691 | 0 | 0 | 0 |
| Pre-tax Income | -31,488 | -7,522 | -21,910 | -16,628 | -16,657 |
| Net Income Continuous | -31,488 | -7,522 | -21,910 | -16,628 | -16,657 |
| Net Income | $-31,488 | $-7,522 | $-21,910 | $-16,628 | $-16,657 |
| EPS Basic Total Ops | -2.23 | -0.57 | -1.73 | -1.35 | -1.39 |
| EPS Basic Continuous Ops | -2.23 | -0.58 | -1.73 | -1.35 | -1.39 |
| EPS Diluted Total Ops | -2.23 | -0.57 | -1.73 | -1.35 | -1.39 |
| EPS Diluted Continuous Ops | -2.23 | -0.58 | -1.73 | -1.35 | -1.39 |
| EBITDA(a) | $-27,471 | $-1,453 | $-20,597 | $-17,243 | $-13,332 |